Pentachlorophenol

Pentachlorophenol

SCHEMBL301602

C=CC(=O)O.OCC(CO)(CO)COCC(CO)(CO)CO.Oc1c(Cl)c(Cl)c(Cl)c(Cl)c1Cl

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.40
TP53 P04637 1/20 0.40
CYP3A4 P08684 1/20 0.40
MAPK1 P28482 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
HIF1A Q16665 1/20 0.40
LMNA P02545 2/20 0.32
MEN1 O00255 1/20 0.32
MAPT P10636 1/20 0.32
HPGD P15428 1/20 0.32
TSHR P16473 1/20 0.32
KMT2A Q03164 1/20 0.32
HSD17B10 Q99714 1/20 0.32
THRB P10828 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lindane SCHEMBL2785151 0.94 ALDH1A1 (0.36) ALDH1A1TP53CYP3A4MAPK1SMN1; SMN2
Pentachlorophenol SCHEMBL2178192 0.94 ALDH1A1 (0.36) ALDH1A1TP53CYP3A4MAPK1SMN1; SMN2
Pentachlorophenol SCHEMBL20267956 0.94 ALDH1A1 (0.36) ALDH1A1TP53CYP3A4MAPK1SMN1; SMN2
Pentachlorophenol SCHEMBL18114673 0.94 ALDH1A1 (0.36) ALDH1A1TP53CYP3A4MAPK1SMN1; SMN2
Pentachlorophenol SCHEMBL21381899 0.89 ALDH1A1 (0.33) ALDH1A1TP53CYP3A4MAPK1SMN1; SMN2
Pentachlorophenol SCHEMBL1702812 0.86 ALDH1A1 (0.44) ALDH1A1TP53CYP3A4MAPK1SMN1; SMN2
Acrylic Acid SCHEMBL11137999 0.84 ALDH1A1 (0.52) ALDH1A1TP53CYP3A4MAPK1SMN1; SMN2
Acrylic Acid SCHEMBL701228 0.84 ALDH1A1 (0.52) ALDH1A1TP53CYP3A4MAPK1SMN1; SMN2
Acrylic Acid SCHEMBL740134 0.84 ALDH1A1 (0.52) ALDH1A1TP53CYP3A4MAPK1SMN1; SMN2
Acrylic Acid SCHEMBL301603 0.84 ALDH1A1 (0.52) ALDH1A1TP53CYP3A4MAPK1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 233 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240016709-A1 BIODEGRADABLE MICROCAPSULES. PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF ISP INVESTMENTS LLC (US) 2024-01-18 US claimed
EP-4181858-A1 BIODEGRADABLE MICROCAPSULES. PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF ISP Investments LLC (US) 2023-05-24 EP claimed
WO-2022013821-A1 BIODEGRADABLE MICROCAPSULES. PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF ISP INVESTMENTS LLC (US) 2022-01-20 WO claimed
WO-2021215647-A1 RADIATION CURABLE COMPOSITION FOR 3D PRINTING (주)경인양행 (KR) 2021-10-28 WO claimed
CN-102317397-B Radiation curable adhesive composition for optical components and adhesive optical component SOKEN KAGAKU KK 2014-03-05 CN claimed
US-8580144-B2 Blue phase liquid crystal nanocomposites and devices containing the same KENT STATE UNIVERSITY (US) 2013-11-12 US claimed
US-20120262662-A1 BLUE PHASE LIQUID CRYSTAL NANOCOMPOSITES AND DEVICES CONTAINING THE SAME KENT STATE UNIVERSITY (US) 2012-10-18 US claimed
WO-2010016075-A1 ULTRAVIOLET/THERMAL MIXED PAINTING COMPOSITION (DUAL CURE) TO BE USED AS A PRE-METALLI ZATION PRIMER UNDER VACUUM QUANTUM TECHNOLOGIES S.R.L. (IT) 2010-02-11 WO claimed
US-7157502-B2 Polymerizable dental barrier material PULPDENT CORPORATION (US) 2007-01-02 US claimed
WO-2004073540-A2 POLYMERIZABLE DENTAL BARRIER MATERIAL PULPDENT CORPORATION (US) 2004-09-02 WO claimed
US-20040161724-A1 Polymerizable dental barrier material PULPDENT CORPORATION 2004-08-19 US claimed
US-6455653-B1 ETHOXYLATED BISPHENOL A, DI(METH)ACRYLATE, BENZYL (METH)ACRYLATE, TETRAHYDROFURFURYL (METH)ACRYLATE, AND DIPENTAERYTHRITOL PENTA(METH)ACRYLATE; SPECTACLE LENS MADE BY CASTING JOHNSON & JOHNSON VISION CARE, INC. 2002-09-24 US claimed
EP-0321683-B1 Adhesive composition which bonds to collagen and calcium DENTSPLY INT INC (US) 1994-01-19 EP claimed
EP-0321683-A1 Adhesive composition which bonds to collagen and calcium DENTSPLY INTERNATIONAL, INC. (US) 1989-06-28 EP claimed
US-4814423-A TEETH, FILLINGS, UNSATURATED PHOSPHATES DENTSPLY RESEARCH & DEVELOPMENT CORP. (US) 1989-03-21 US claimed
WO-2026104575-A1 COMPOSITION COMPRISING PRE-POLYMER TISSIUM SA (FR) 2026-05-21 WO disclosed
WO-2026104576-A1 COMPOSITION COMPRISING PRE-POLYMER WITH IMPROVED MECHANICAL PROPERTIES TISSIUM SA (FR) 2026-05-21 WO disclosed
EP-0409555-A2 Heat-sensitive transfer recording medium of the sublimation type MITSUBISHI RAYON CO., LTD. (JP) 1991-01-23 EP disclosed
EP-0351830-A2 Polyester compositions with improved properties UNION CARBIDE CHEMICALS AND PLASTICS COMPANY INC. (a New York corporation) (US) 1990-01-24 EP disclosed
EP-0324483-A2 Method for forming hard coat on polyolefin MITSUBISHI PETROCHEMICAL CO., LTD. (JP) 1989-07-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240016709-A1 BIODEGRADABLE MICROCAPSULES. PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF LIPA, CETP, LIPE ALDH1A1 3611/4885TP53 153/4885CYP3A4 2335/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.